Jupiter Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Jupiter Asset Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-524,079	Closed	-$3.5M	–	556
2023 Q3	$3.5M	Buy	524,079 +207,277	+65%	+$1.72M	0.04%	277
2023 Q2	$2.86M	Buy	316,802 +229,687	+264%	+$2.03M	0.03%	330
2023 Q1	$632K	Buy	+87,115	New	+$646K	0.01%	363

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Jupiter Asset Management's PNT Position: Q4 2023 in Review

Jupiter Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 524,079 shares — an estimated $3.5M sold.

Jupiter Asset Management first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $3.5M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Jupiter Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Jupiter Asset Management sold 524,079 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $3.5M.
Jupiter Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Jupiter Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $3.5M in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Jupiter Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.